Literature DB >> 22382212

Prehypertension - time to act.

Preeti Gupta1, Shankar Prasad Nagaraju, Ankur Gupta, Kiran B Mandya Chikkalingaiah.   

Abstract

The term "prehypertension" defined as systolic blood pressure between 120 and 139 mmHg and/or diastolic pressures between 80 and 89 mmHg has now gained general acceptance. Prehypertension is associated with ~3-fold greater likelihood of developing hypertension, and roughly twice the number of cardiovascular events, than BP < 120/80 mmHg. When compared with normotensive individuals, prehypertensive individuals are more likely to be overweight and obese, to have other cardiovascular risk factors, to progress to established hypertension, and to experience premature clinical cardiovascular disease. The major unresolved issue is the appropriate management of such patients. Lifestyle modification is recommended for all patients with prehypertension as it effectively reduces rate of cardiovascular events. Presently pharmacological therapy is indicated for some patients with prehypertension who have specific comorbidities, including diabetes mellitus, chronic kidney disease, and coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22382212

Source DB:  PubMed          Journal:  Saudi J Kidney Dis Transpl        ISSN: 1319-2442


  9 in total

1.  Blood pressure, left ventricular geometry, and systolic function in children exposed to inorganic arsenic.

Authors:  Citlalli Osorio-Yáñez; Julio C Ayllon-Vergara; Laura Arreola-Mendoza; Guadalupe Aguilar-Madrid; Erika Hernández-Castellanos; Luz C Sánchez-Peña; Luz M Del Razo
Journal:  Environ Health Perspect       Date:  2015-02-27       Impact factor: 9.031

2.  Prehypertension and incidence of cardiovascular disease: a meta-analysis.

Authors:  Yuli Huang; Sheng Wang; Xiaoyan Cai; Weiyi Mai; Yunzhao Hu; Hongfeng Tang; Dingli Xu
Journal:  BMC Med       Date:  2013-08-02       Impact factor: 8.775

3.  Impact of prehypertension on left ventricular mass and QT dispersion in adult black Nigerians.

Authors:  O K Ale; J N Ajuluchukwu; D A Ok; A C Mbakwem
Journal:  Cardiovasc J Afr       Date:  2014 Mar-Apr       Impact factor: 1.167

4.  Prevalence and risk factors associated with prehypertension in Shunde District, southern China.

Authors:  Yuli Huang; Wenke Qiu; Changhua Liu; Dingji Zhu; Jinghai Hua; Xiaoyan Cai; Yanxian Wu; Yunzhao Hu; Dingli Xu
Journal:  BMJ Open       Date:  2014-11-13       Impact factor: 2.692

5.  Prehypertension and the risk of coronary heart disease in Asian and Western populations: a meta-analysis.

Authors:  Yuli Huang; Xiaoyan Cai; Changhua Liu; Dingji Zhu; Jinghai Hua; Yunzhao Hu; Jian Peng; Dingli Xu
Journal:  J Am Heart Assoc       Date:  2015-02-19       Impact factor: 5.501

6.  A Meta-Analysis on Prehypertension and Chronic Kidney Disease.

Authors:  Yang Li; Peng Xia; Lubin Xu; Yang Wang; Limeng Chen
Journal:  PLoS One       Date:  2016-06-01       Impact factor: 3.240

7.  Arsenic exposure assists ccm3 genetic polymorphism in elevating blood pressure.

Authors:  Yanfang Gao; Zhiqiang Zhao; Linqing Yang; Xinxia Liu; Xiumei Xing; Huimin Zhang; Jianpei Yun; Xiaoyan Ou; Xiaolin Su; Yao Lu; Yi Sun; Yarui Yang; Jun Jiang; Dong Cui; Zhixiong Zhuang; Yun He
Journal:  Oncotarget       Date:  2017-12-21

8.  Blood pressure and noncommunicable diseases in middle-aged and older adults in China.

Authors:  Yinghui You; Jincai Wang; Wenjie Teng; Guifeng Ma; Pengtao Liu
Journal:  PLoS One       Date:  2018-11-02       Impact factor: 3.240

9.  Predictors of Hypertension in Mauritians with Normotension and Prehypertension at Baseline: A Cohort Study.

Authors:  Sudhirsen Kowlessur; Zhibin Hu; Jaysing Heecharan; Jianming Wang; Juncheng Dai; Jaakko O Tuomilehto; Stefan Söderberg; Paul Zimmet; Noël C Barengo
Journal:  Int J Environ Res Public Health       Date:  2018-07-02       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.